A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression

by palligoelme@gmail.com | Sep 15, 2025 | Clinical Trials

​ Conditions: Glioblastoma Interventions: Other: samples Sponsors: University Hospital, Bordeaux; University of Bordeaux Not yet recruiting Conditions: Glioblastoma Interventions: Other: samples Sponsors: University Hospital, Bordeaux; University of Bordeaux Not yet...

The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver Cirrhosis

by palligoelme@gmail.com | Sep 15, 2025 | Clinical Trials

​ Conditions: Cirrhosis; Decompensation; Transjugular Intrahepatic Portosystemic Shunt (TIPS); Survival Analysis Sponsors: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology; Zhongnan Hospital; Yichang Central People’s...

The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC

by palligoelme@gmail.com | Sep 15, 2025 | Clinical Trials

​ Conditions: Recurrent Cervical Cancer Interventions: Drug: RC48; Drug: QL1706 Sponsors: Qilu Hospital of Shandong University Not yet recruiting Conditions: Recurrent Cervical Cancer Interventions: Drug: RC48; Drug: QL1706 Sponsors: Qilu Hospital of Shandong...

Automated Text Message Reminders to Promote Hearing Aid Adoption

by palligoelme@gmail.com | Sep 12, 2025 | Clinical Trials

​ Conditions: Hearing Loss Interventions: Behavioral: Automated text message reminder Sponsors: Stanford University Not yet recruiting Conditions: Hearing Loss Interventions: Behavioral: Automated text message reminder Sponsors: Stanford University Not yet...

The Effect of REgulation of PArathyroId hoRmone in Patients With Chronic Kidney Disease to Investigate the Change in Bone Mineral Density

by palligoelme@gmail.com | Sep 12, 2025 | Clinical Trials

​ Conditions: Chronic Kidney Disease Mineral and Bone Disorder Interventions: Other: Treat to target Sponsors: Herlev Hospital Not yet recruiting Conditions: Chronic Kidney Disease Mineral and Bone Disorder Interventions: Other: Treat to target Sponsors: Herlev...